Antidepressant doses under scrutiny for kidney patients
NCT ID NCT07531173
First seen Apr 26, 2026 · Last updated May 23, 2026 · Updated 2 times
Summary
This study examined whether starting a higher dose of two common antidepressants (venlafaxine or duloxetine) increases the risk of serious events like emergency visits, hospital stays, or death within 30 days in older adults (66+) with chronic kidney disease. Researchers analyzed data from over 8,600 patients who were not on dialysis or had a kidney transplant. The goal was to understand if higher doses pose extra danger for this group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.